Skip to main content
. 2020 May 25;12:47. doi: 10.1186/s13098-020-00555-x

Table 2.

Pharmacologic treatment of the study cohort at baseline

All
289
Men
158 (54.7%)
Women
131 (45.3%)
p value
No treatment (n; %) 155; 53.6 81; 51.3 74; 56.5 ns
Metformin (n; %) 84; 29.1 48; 30.4 36; 27.5 ns
Secretagogues (± metformin; n; %) 50; 17.3 29; 18.4 21; 16.0 ns
Anti-hypertensive treatment (n; %) 179; 61.9 103; 65.2 76; 58.0 ns
Statins (n; %) 88; 30.4 50; 31.6 38; 29.0 ns